NCT01930929

Brief Summary

The number of obese is increasing rapidly. Bariatric surgery is used to a greater and greater extent as treatment of obesity to obtain a greater and more permanent weight loss. The currently most commonly used surgical method is the gastric bypass (RYGB), which so far has proved to be the most effective way to achieve a greater and more permanent weight loss, reduction and maybe even elimination of many of the obesity-related health complication (diabetes, sleep apnea, pain due to osteoarthrosis etc.). Bariatric surgery, including RYGB is also associated with medical and nutritional complications. This will be a natural consequence of the fact that the food bypasses virtually the entire ventricle and 100-150 cm of the upper part of the small intestine after a RYGB. Therefore, problems with uptake of for example B12, iron, folate, thiamin, fat-soluble vitamins (Vitamins A, D, E and K) copper, zinc and selenium are expected. In the light of this, it is decided that all RYGB operated patients must take vitamin B12, iron and vitamin D substitution. In spite of this, many develop various nutritional problems after RYGB. In addition to these nutritional complications are complications such as hypoglycaemia and gallstone attacks after RYGB. Nevertheless there is no comprehensive inventory of the occurrence of nutritional complications after bariatric surgery neither in Denmark nor in an international context. Thus there is no consensus on an optimal postoperative prevention of complications. An overview of the occurrence of these problems will be important for assessing and determine the indications for bariatric surgery as well as to optimize the prevention of complications. To enlighten this we will conduct a cohort study of complications by investigating hospitalizations and deaths after RYGB. Moreover we will get an overview on medication use before and after RYGB operation in the Central Denmark Region and in the North Denmark Region 2006-2011 (about 5000 patients).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
9,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2013

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 19, 2013

Completed
10 days until next milestone

First Posted

Study publicly available on registry

August 29, 2013

Completed
2 months until next milestone

Study Start

First participant enrolled

November 1, 2013

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2016

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2016

Completed
Last Updated

November 4, 2020

Status Verified

December 1, 2015

Enrollment Period

2.8 years

First QC Date

August 19, 2013

Last Update Submit

November 3, 2020

Conditions

Keywords

Bariatric surgeryComplicationsDrugs

Outcome Measures

Primary Outcomes (1)

  • Surgical complications

    Ileus, pain, infections, kidney stones

    2-7 years

Secondary Outcomes (1)

  • Use of drugs before and after bariatric surgery

    2-7 years

Study Arms (1)

Bariatric surgery operated patients

All patients who have operated in the Central and North Denmark Region 2006-2011

Procedure: Bariatric surgery

Interventions

Also known as: All patients with a primary gastric bypass operation
Bariatric surgery operated patients

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients WHO have had bariatric surgery in the Central and North Denmark Region 2006-2011

You may qualify if:

  • Bariatric surgery 2006-2011
  • resident in the Central and North Denmark Region

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Endocrinology and Internal Medicine

Aarhus, 8000, Denmark

Location

MeSH Terms

Interventions

Bariatric Surgery

Intervention Hierarchy (Ancestors)

BariatricsObesity ManagementTherapeuticsSurgical Procedures, Operative

Study Officials

  • Bjorn Richelsen, Professor, DMSc

    Department of Medicine and Endocrinology, Aarhus University Hospital

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 19, 2013

First Posted

August 29, 2013

Study Start

November 1, 2013

Primary Completion

August 1, 2016

Study Completion

September 1, 2016

Last Updated

November 4, 2020

Record last verified: 2015-12

Locations